Global Reduced Glutathione for Injection 麻豆原创 Growth 2024-2030

Publication ID:

LPI04245385

Publication Date:

April 12, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Reduced glutathione for injection is used to prevent and treat tissue cell damage caused by drugs (such as chemotherapy drugs, anti-tuberculosis drugs, psychiatric drugs, paracetamol, etc.), radiotherapy, alcohol and organophosphorus;It has a protective effect on liver damage caused by various causes.
The global Reduced Glutathione for Injection market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淩educed Glutathione for Injection Industry Forecast鈥� looks at past sales and reviews total world Reduced Glutathione for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Reduced Glutathione for Injection sales for 2024 through 2030. With Reduced Glutathione for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Reduced Glutathione for Injection industry.
This Insight Report provides a comprehensive analysis of the global Reduced Glutathione for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Reduced Glutathione for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Reduced Glutathione for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Reduced Glutathione for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Reduced Glutathione for Injection.
United States market for Reduced Glutathione for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Reduced Glutathione for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Reduced Glutathione for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Reduced Glutathione for Injection players cover Biomedica Foscama, Fuan Pharmaceutical (Group) Co., Ltd., Shenyang Shuangding Pharmaceutical Co., Ltd., Beijing Sihuan Kebao Pharmaceutical Co., Ltd. and Sinopharm Group Co. Ltd. and etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Reduced Glutathione for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
0.9g
1.2g
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biomedica Foscama
Fuan Pharmaceutical (Group) Co., Ltd.
Shenyang Shuangding Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Sinopharm Group Co. Ltd.
CSPC OUYI Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Reduced Glutathione for Injection market?
What factors are driving Reduced Glutathione for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Reduced Glutathione for Injection market opportunities vary by end market size?
How does Reduced Glutathione for Injection break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Reduced Glutathione for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Reduced Glutathione for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Reduced Glutathione for Injection by Country/Region, 2019, 2023 & 2030
2.2 Reduced Glutathione for Injection Segment by Type
2.2.1 0.9g
2.2.2 1.2g
2.3 Reduced Glutathione for Injection Sales by Type
2.3.1 Global Reduced Glutathione for Injection Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Reduced Glutathione for Injection Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Reduced Glutathione for Injection Sale Price by Type (2019-2024)
2.4 Reduced Glutathione for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Reduced Glutathione for Injection Sales by Application
2.5.1 Global Reduced Glutathione for Injection Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Reduced Glutathione for Injection Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Reduced Glutathione for Injection Sale Price by Application (2019-2024)
3 Global Reduced Glutathione for Injection by Company
3.1 Global Reduced Glutathione for Injection Breakdown Data by Company
3.1.1 Global Reduced Glutathione for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Reduced Glutathione for Injection Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Reduced Glutathione for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Reduced Glutathione for Injection Revenue by Company (2019-2024)
3.2.2 Global Reduced Glutathione for Injection Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Reduced Glutathione for Injection Sale Price by Company
3.4 Key Manufacturers Reduced Glutathione for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Reduced Glutathione for Injection Product Location Distribution
3.4.2 Players Reduced Glutathione for Injection Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Reduced Glutathione for Injection by Geographic Region
4.1 World Historic Reduced Glutathione for Injection 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Reduced Glutathione for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Reduced Glutathione for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Reduced Glutathione for Injection 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Reduced Glutathione for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Reduced Glutathione for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Reduced Glutathione for Injection Sales Growth
4.4 APAC Reduced Glutathione for Injection Sales Growth
4.5 Europe Reduced Glutathione for Injection Sales Growth
4.6 Middle East & Africa Reduced Glutathione for Injection Sales Growth
5 Americas
5.1 Americas Reduced Glutathione for Injection Sales by Country
5.1.1 Americas Reduced Glutathione for Injection Sales by Country (2019-2024)
5.1.2 Americas Reduced Glutathione for Injection Revenue by Country (2019-2024)
5.2 Americas Reduced Glutathione for Injection Sales by Type
5.3 Americas Reduced Glutathione for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Reduced Glutathione for Injection Sales by Region
6.1.1 APAC Reduced Glutathione for Injection Sales by Region (2019-2024)
6.1.2 APAC Reduced Glutathione for Injection Revenue by Region (2019-2024)
6.2 APAC Reduced Glutathione for Injection Sales by Type
6.3 APAC Reduced Glutathione for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Reduced Glutathione for Injection by Country
7.1.1 Europe Reduced Glutathione for Injection Sales by Country (2019-2024)
7.1.2 Europe Reduced Glutathione for Injection Revenue by Country (2019-2024)
7.2 Europe Reduced Glutathione for Injection Sales by Type
7.3 Europe Reduced Glutathione for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Reduced Glutathione for Injection by Country
8.1.1 Middle East & Africa Reduced Glutathione for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Reduced Glutathione for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Reduced Glutathione for Injection Sales by Type
8.3 Middle East & Africa Reduced Glutathione for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Reduced Glutathione for Injection
10.3 Manufacturing Process Analysis of Reduced Glutathione for Injection
10.4 Industry Chain Structure of Reduced Glutathione for Injection
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Reduced Glutathione for Injection Distributors
11.3 Reduced Glutathione for Injection Customer
12 World Forecast Review for Reduced Glutathione for Injection by Geographic Region
12.1 Global Reduced Glutathione for Injection 麻豆原创 Size Forecast by Region
12.1.1 Global Reduced Glutathione for Injection Forecast by Region (2025-2030)
12.1.2 Global Reduced Glutathione for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Reduced Glutathione for Injection Forecast by Type
12.7 Global Reduced Glutathione for Injection Forecast by Application
13 Key Players Analysis
13.1 Biomedica Foscama
13.1.1 Biomedica Foscama Company Information
13.1.2 Biomedica Foscama Reduced Glutathione for Injection Product Portfolios and Specifications
13.1.3 Biomedica Foscama Reduced Glutathione for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Biomedica Foscama Main Business Overview
13.1.5 Biomedica Foscama Latest Developments
13.2 Fuan Pharmaceutical (Group) Co., Ltd.
13.2.1 Fuan Pharmaceutical (Group) Co., Ltd. Company Information
13.2.2 Fuan Pharmaceutical (Group) Co., Ltd. Reduced Glutathione for Injection Product Portfolios and Specifications
13.2.3 Fuan Pharmaceutical (Group) Co., Ltd. Reduced Glutathione for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Fuan Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.2.5 Fuan Pharmaceutical (Group) Co., Ltd. Latest Developments
13.3 Shenyang Shuangding Pharmaceutical Co., Ltd.
13.3.1 Shenyang Shuangding Pharmaceutical Co., Ltd. Company Information
13.3.2 Shenyang Shuangding Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product Portfolios and Specifications
13.3.3 Shenyang Shuangding Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Shenyang Shuangding Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Shenyang Shuangding Pharmaceutical Co., Ltd. Latest Developments
13.4 Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
13.4.1 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Company Information
13.4.2 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product Portfolios and Specifications
13.4.3 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Latest Developments
13.5 Sinopharm Group Co. Ltd.
13.5.1 Sinopharm Group Co. Ltd. Company Information
13.5.2 Sinopharm Group Co. Ltd. Reduced Glutathione for Injection Product Portfolios and Specifications
13.5.3 Sinopharm Group Co. Ltd. Reduced Glutathione for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sinopharm Group Co. Ltd. Main Business Overview
13.5.5 Sinopharm Group Co. Ltd. Latest Developments
13.6 CSPC OUYI Pharmaceutical Co., Ltd.
13.6.1 CSPC OUYI Pharmaceutical Co., Ltd. Company Information
13.6.2 CSPC OUYI Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Product Portfolios and Specifications
13.6.3 CSPC OUYI Pharmaceutical Co., Ltd. Reduced Glutathione for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CSPC OUYI Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 CSPC OUYI Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.